# Myogen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myogen

- Industry: Pharmaceuticals
- Headquarters: Westminster, US
- Total disclosed funding: $106M
- Latest round: Series D (Aug 29, 2003)
- Investors on record: 13

## About

Founded in 1996 and based in Colorado, US, Myogen, Inc. operates as a biopharmaceutical company that develops small molecule therapeutics for the treatment of cardiovascular disorders.

## Funding rounds

- Series D, Aug 29, 2003, $40M — InterWest Partners, New Enterprise Associates, Sequel Venture Partners, Greenspring Associates, Presidio Partners, Aisling Capital, Pacific Rim Ventures
- Series D, Jan 3, 2002, $14M — Covera Ventures, Aisling Capital, China Development Bank Capital, Silicon Valley Bank, Tenex Medical Investors
- Series D, Aug 28, 2001, $52M — Adams Street Partners, InterWest Partners, New Enterprise Associates, Sequel Venture Partners, Greenspring Associates, Presidio Partners, JP Morgan Asset Management, Pacific Rim Ventures

## Investors

- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series D
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series D
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series D
- Sequel Venture Partners (https://capitalatlas.ai/funds/sequel-venture-partners) — Series D
- Greenspring Associates (https://capitalatlas.ai/funds/greenspring-associates) — Series D
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series D
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series D
- Pacific Rim Ventures (https://capitalatlas.ai/funds/pacific-rim-ventures) — Series D
- Covera Ventures (https://capitalatlas.ai/funds/covera-ventures) — Series D
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series D
- China Development Bank Capital — Series D
- Silicon Valley Bank — Series D
- Tenex Medical Investors (https://capitalatlas.ai/funds/tenex-medical-investors) — Series D